» Articles » PMID: 29560554

Effects of Exosomes from LPS-activated Macrophages on Adipocyte Gene Expression, Differentiation, and Insulin-dependent Glucose Uptake

Overview
Specialties Biochemistry
Physiology
Date 2018 Mar 22
PMID 29560554
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity is usually associated with low-grade inflammation, which determines the appearance of comorbidities like atherosclerosis and insulin resistance. Infiltrated macrophages in adipose tissue are partly responsible of this inflammatory condition. Numerous studies point to the existence of close intercommunication between macrophages and adipocytes and pay particular attention to the proinflammatory cytokines released by both cell types. However, it has been recently described that in both, circulation and tissue level, there are extracellular vesicles (including microvesicles and exosomes) containing miRNAs, mRNAs, and proteins that can influence the inflammatory response. The objective of the present research is to investigate the effect of exosomes released by lipopolysaccharide (LPS)-activated macrophages on gene expression and cell metabolism of adipocytes, focusing on the differential exosomal miRNA pattern between LPS- and non-activated macrophages. The results show that the exosomes secreted by the macrophages do not influence the preadipocyte-to-adipocyte differentiation process, fat storage, and insulin-mediated glucose uptake in adipocytes. However, exosomes induce changes in adipocyte gene expression depending on their origin (LPS- or non-activated macrophages), including genes such as CXCL5, SOD, TNFAIP3, C3, and CD34. Some of the pathways or metabolic processes upregulated by exosomes from LPS-activated macrophages are related to inflammation (complement activation, regulation of reactive oxygen species, migration and activation of leukocyte, and monocyte chemotaxis), carbohydrate catabolism, and cell activation. miR-530, chr9_22532, and chr16_34840 are more abundant in exosomes from LPS-activated macrophages, whereas miR-127, miR-143, and miR-486 are more abundant in those secreted by non-activated macrophages.

Citing Articles

Extracellular vesicles in tumor immunity: mechanisms and novel insights.

Kuang L, Wu L, Li Y Mol Cancer. 2025; 24(1):45.

PMID: 39953480 PMC: 11829561. DOI: 10.1186/s12943-025-02233-w.


Metabolic Messengers: small extracellular vesicles.

Rohm T, Cunha E Rocha K, Olefsky J Nat Metab. 2025; 7(2):253-262.

PMID: 39920357 DOI: 10.1038/s42255-024-01214-5.


Macrophage-derived extracellular vesicles as new players in chronic non-communicable diseases.

Lin F, Luo H, Wang J, Li Q, Zha L Front Immunol. 2025; 15:1479330.

PMID: 39896803 PMC: 11782043. DOI: 10.3389/fimmu.2024.1479330.


Tools for regulating metabolic diseases: extracellular vesicles from adipose macrophages.

Zhang L, Lou K, Zhang Y, Leng Y, Huang Y, Liao X Front Endocrinol (Lausanne). 2024; 15:1510712.

PMID: 39735643 PMC: 11674605. DOI: 10.3389/fendo.2024.1510712.


Exosomal miRNAs and isomiRs: potential biomarkers for type 2 diabetes mellitus.

Sou Y, Chilian W, Ratnam W, Zain S, Syed Abdul Kadir S, Pan Y Precis Clin Med. 2024; 7(3):pbae021.

PMID: 39347441 PMC: 11438237. DOI: 10.1093/pcmedi/pbae021.


References
1.
Suganami T, Nishida J, Ogawa Y . A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol. 2005; 25(10):2062-8. DOI: 10.1161/01.ATV.0000183883.72263.13. View

2.
Lin J, Liu Q, Zhang H, Huang X, Zhang R, Chen S . C1q/Tumor necrosis factor-related protein-3 protects macrophages against LPS-induced lipid accumulation, inflammation and phenotype transition via PPARγ and TLR4-mediated pathways. Oncotarget. 2017; 8(47):82541-82557. PMC: 5669909. DOI: 10.18632/oncotarget.19657. View

3.
Huang-Doran I, Zhang C, Vidal-Puig A . Extracellular Vesicles: Novel Mediators of Cell Communication In Metabolic Disease. Trends Endocrinol Metab. 2016; 28(1):3-18. DOI: 10.1016/j.tem.2016.10.003. View

4.
Alrob O, Khatib S, Naser S . MicroRNAs 33, 122, and 208: a potential novel targets in the treatment of obesity, diabetes, and heart-related diseases. J Physiol Biochem. 2016; 73(2):307-314. DOI: 10.1007/s13105-016-0543-z. View

5.
Keuper M, Dzyakanchuk A, Amrein K, Wabitsch M, Fischer-Posovszky P . THP-1 Macrophages and SGBS Adipocytes - A New Human in vitro Model System of Inflamed Adipose Tissue. Front Endocrinol (Lausanne). 2012; 2:89. PMC: 3355855. DOI: 10.3389/fendo.2011.00089. View